Related Experiment Videos
Transcription factors: targets for new designer drugs
1Surgical Unit, London Hospital Medical College, University of London, Whitechapel, England, UK.
Abstract:
Many diseases are the result of aberrant regulation of cell and tissue-specific gene expression. At the molecular level they are often characterised by disruption of the cell cycle through inappropriate activation or inactivation of key regulatory proteins, termed nuclear transcription factors (NFs). NF activation is modulated by several potent classes of drug, including steroids, retinoids, and immunosuppressants like cyclosporin A and FK506. While such drugs have wide application, they lack specificity and produce undesired side-effects. Recently, however, the three-dimensional structures of some NFs, as well as their molecular interactions with DNA targets, have been reported and several biochemical pathways involved in altered NF function identified. This is setting the stage for a rational approach to the design of drugs that act in a tissue- or disease-specific manner, target particular genes and proteins, and will combine increased efficacy with reduced side-effects.
Insights
Diseases linked to gene expression errors can be treated with new drugs targeting nuclear transcription factors (NFs). Understanding NF structures and pathways enables precise drug design for better efficacy and fewer side effects.
Area of Science:
- Molecular Biology
- Genetics
- Pharmacology
Background:
- Aberrant regulation of gene expression underlies many diseases.
- Disruption of the cell cycle involves altered nuclear transcription factor (NF) activity.
- Current drugs modulating NF activity lack specificity and cause side effects.
Purpose of the Study:
- To explore the potential for rational drug design targeting nuclear transcription factors (NFs).
- To leverage structural and biochemical insights for developing targeted therapies.
- To improve therapeutic efficacy and reduce adverse effects associated with NF modulation.
Main Methods:
- Analysis of three-dimensional structures of nuclear transcription factors (NFs).
- Investigation of molecular interactions between NFs and DNA targets.
- Identification of biochemical pathways regulating NF function.
Main Results:
- Structural data for several NFs and their DNA interactions are now available.
- Key biochemical pathways influencing NF function have been identified.
- This knowledge facilitates a move towards targeted therapeutic strategies.
Conclusions:
- Structural and mechanistic insights into NFs pave the way for rational drug design.
- Targeted drug development promises tissue- or disease-specific action.
- Future therapies aim for enhanced efficacy with minimized side effects by focusing on specific genes and proteins.